KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xperi (XPER) Gains from Investment Securities (2022 - 2025)

Historic Gains from Investment Securities for Xperi (XPER) over the last 4 years, with Q3 2025 value amounting to $279000.0.

  • Xperi's Gains from Investment Securities rose 40727.27% to $279000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 million, marking a year-over-year increase of 1298000.0%. This contributed to the annual value of $54000.0 for FY2024, which is 4905.66% down from last year.
  • Per Xperi's latest filing, its Gains from Investment Securities stood at $279000.0 for Q3 2025, which was up 40727.27% from $1.1 million recorded in Q2 2025.
  • Xperi's 5-year Gains from Investment Securities high stood at $5.3 million for Q1 2025, and its period low was $55000.0 during Q3 2024.
  • For the 4-year period, Xperi's Gains from Investment Securities averaged around $662769.2, with its median value being $146000.0 (2022).
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first tumbled by 5378.15% in 2024, then soared by 756376.81% in 2025.
  • Xperi's Gains from Investment Securities (Quarter) stood at $146000.0 in 2022, then soared by 284.93% to $562000.0 in 2023, then increased by 1.42% to $570000.0 in 2024, then crashed by 51.05% to $279000.0 in 2025.
  • Its Gains from Investment Securities was $279000.0 in Q3 2025, compared to $1.1 million in Q2 2025 and $5.3 million in Q1 2025.